Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VC8Z
|
|||
| Drug Name |
Trehalose
|
|||
| Synonyms |
trehalose; D-Trehalose; 99-20-7; alpha,alpha-trehalose; Mycose; Ergot sugar; alpha-D-Trehalose; D-(+)-Trehalose; alpha,alpha'-Trehalose; Trehaose; Treha; alpha-Trehalose; UNII-B8WCK70T7I; alpha-D-glucopyranosyl-alpha-D-glucopyranoside; D(+)-Trehalose; D-(+)-Trehalose, anhydrous; Natural trehalose; TREHALOSE, DIHYDRATE; alpha,alpha'-D-Trehalose; alpha-D-Glucopyranoside, alpha-D-glucopyranosyl; B8WCK70T7I; CHEBI:16551; alpha-D-glucopyranosyl alpha-D-glucopyranoside; Neotrehalose; Thealoz; NSC 2093; TRE; Trehalose, alpha,alpha'-; Trehalo
Click to Show/Hide
|
|||
| Indication | Muscular dystrophy [ICD-11: 8C70; ICD-10: G71.0] | Phase 2 | [1] | |
| Oculopharyngeal muscular dystrophy [ICD-11: 9C82.1; ICD-10: H49-H52] | Phase 2 | [2] | ||
| Spinal cerebellar ataxia type 3 [ICD-11: 8A03] | Phase 2 | [1] | ||
| Company |
BioBlast Pharma New Haven, CT
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H22O11
|
|||
| Canonical SMILES |
C(C1C(C(C(C(O1)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)O
|
|||
| InChI |
1S/C12H22O11/c13-1-3-5(15)7(17)9(19)11(21-3)23-12-10(20)8(18)6(16)4(2-14)22-12/h3-20H,1-2H2/t3-,4-,5-,6-,7+,8+,9-,10-,11-,12-/m1/s1
|
|||
| InChIKey |
HDTRYLNUVZCQOY-LIZSDCNHSA-N
|
|||
| CAS Number |
CAS 99-20-7
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:16551
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.